PCZ-207

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePCZ-207
Drug Alias NamePCZ-207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 modulators
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChengdu Aiqun Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChengdu Aiqun Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsMetabolic Syndrome

Other Information

ATC CodeN/A
Related LinksN/A